320 related articles for article (PubMed ID: 3524218)
1. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside.
DeJace P; Klastersky J
Am J Med; 1986 Jun; 80(6B):29-38. PubMed ID: 3524218
[TBL] [Abstract][Full Text] [Related]
2. [A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside].
Dejace P; Klastersky J
Infection; 1987; 15 Suppl 4():S158-67. PubMed ID: 3312028
[TBL] [Abstract][Full Text] [Related]
3. The results of a randomized trial of empirical antibiotic treatment in febrile neutropenic patients with four beta-lactam/aminoglycoside combinations.
Hann I; Noone P; Prentice HG; Sage R; Blacklock H; Stirling L; Gray R; Corringham R; Boesen E; Mohiuddin J
J Antimicrob Chemother; 1983 May; 11 Suppl C():57-63. PubMed ID: 6352605
[No Abstract] [Full Text] [Related]
4. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia.
Paul M; Dickstein Y; Schlesinger A; Grozinsky-Glasberg S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD003038. PubMed ID: 23813455
[TBL] [Abstract][Full Text] [Related]
5. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
Walsh TJ; Schimpff SC
Schweiz Med Wochenschr Suppl; 1983; 14():58-63. PubMed ID: 6361993
[TBL] [Abstract][Full Text] [Related]
7. Management in the febrile, neutropenic patient with cancer: therapeutic considerations.
Brown AE
J Pediatr; 1985 Jun; 106(6):1035-42. PubMed ID: 3889253
[TBL] [Abstract][Full Text] [Related]
8. Overview of empiric antibiotic therapy for the febrile neutropenic patient.
Schimpff SC
Rev Infect Dis; 1985; 7 Suppl 4():S734-40. PubMed ID: 3878564
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
[TBL] [Abstract][Full Text] [Related]
10. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
Paul M; Lador A; Grozinsky-Glasberg S; Leibovici L
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003344. PubMed ID: 24395715
[TBL] [Abstract][Full Text] [Related]
11. Use of aminoglycosides in immunocompromised patients.
Young LS
Am J Med; 1985 Jul; 79(1A):21-7. PubMed ID: 4025366
[TBL] [Abstract][Full Text] [Related]
12. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
[TBL] [Abstract][Full Text] [Related]
13. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Zinner SH; Dudley M; Blaser J
Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
[TBL] [Abstract][Full Text] [Related]
14. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
[TBL] [Abstract][Full Text] [Related]
15. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
Nichols L; Maki DG
Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
[TBL] [Abstract][Full Text] [Related]
16. Combination antibiotic therapy in pediatrics.
Chadwick EG; Yogev R; Shulman ST
Am J Med; 1986 Jun; 80(6B):166-71. PubMed ID: 3728528
[TBL] [Abstract][Full Text] [Related]
17. Empiric antibiotic therapy for granulocytopenic cancer patients.
Schimpff SC
Am J Med; 1986 May; 80(5C):13-20. PubMed ID: 3521270
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of antipseudomonal antimicrobic agents.
Gilbert DN
Antibiot Chemother (1971); 1985; 36():111-33. PubMed ID: 3923909
[TBL] [Abstract][Full Text] [Related]
19. Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials.
Marcus R; Paul M; Elphick H; Leibovici L
Int J Antimicrob Agents; 2011 Jun; 37(6):491-503. PubMed ID: 21292449
[TBL] [Abstract][Full Text] [Related]
20. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
